Navigation Links
Alpharma in Medical News

King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion

Combination to Create a Leading Specialty Pharmaceutical Company with Greater Commercialization Capabilities, Expanded Portfolio of Pain Management Products and a Strengthened Pipeline King Extends Tender Offer Through December 19, 2008 BRISTOL, Tenn. and BRIDGEWATER, N.J., Nov....

Alpharma's Reach Teach Learn Initiative Targets Youth and Consumer Awareness

...ure that honest, educated decisions are made. alpharma Inc., Animal Health announced the launch of Reach...ellinger, Global Leader, Sales & Marketing for alpharma Inc., Animal Health. "These initiatives are small ...an important role in the future of agriculture and alpharma is reaching out to help them glean a thorough unde...

Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit

...amp; Critical Care Medicine, Division of Pain Medicine, formerly Chief Medical Officer, Senior Vice President Clinical Research & Medical Affairs, alpharma Inc. For more information about this conference, please visit www.arrowheadpublishers.com , or call 1-312-244-3703, ext. 4. ### Read the f...

DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy

...rch and medical affairs for pain products while at alpharma and Abbott, and first-hand experience with the reg...(TM) and other programs." Dr. Stauffer was at alpharma Inc. from 2004 to 2009, where his latest position prior to the acquisition of alpharma by King Pharmaceuticals was as Chief Medical Offic...

Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion

...nderstanding and knowledge of the company as well as pharmaceutical development. His previous positions at highly reputable organizations such as PPD, alpharma (Actavis), Solvay Pharmaceuticals and Solvay Animal Health, to name a few, has helped develop his expertise in a range of areas, including chromatogra...

National Family Partnership Designates October 27th 'Lock Your Meds' Day

...ve social activities for youth. About Alpharma alpharma Inc. (NYSE: ALO ) is a global specialty pharmaceu...ship positions in products for humans and animals. alpharma is presently active in more than 80 countries. alpharma has a growing branded pharmaceutical franchise in ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...als (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: AN...

Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector

...tt served as CEO of Diad Research, a technology start-up. From 1990 to 1997, he held various senior management positions with pharmaceutical companies alpharma Inc. and NMC Laboratories. Barrett is a past chairman of the Generic Pharmaceutical Association and is on the board of ambassadors of Johns Hopkins Sc...

KADIAN Efficacy Not Affected by Alcohol Consumption

...e extended-release) Capsules have been released by alpharma Inc. (NYSE: ALO), a leading pharmaceutical company... Results of this pharmacokinetic study, which alpharma conducted in response to a request by the U.S. Foo...ce President, Clinical Research & Medical Affairs, alpharma Pharmaceuticals Division Inc. "We believe this inf...
Alpharma in Medical Technology

Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting

...IDGEWATER, N.J., Sept. 9 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a global specialty pharmaceuti...ogic abuse-deterrent, extended-release opioid that alpharma is developing for the treatment of moderate to sev... President of Clinical Research & Medical Affairs, alpharma Pharmaceuticals. "We look forward to collaborating...

Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session

... TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a global specialty pharmaceuti...ogic abuse-deterrent, extended-release opioid that alpharma is developing for the treatment of moderate to sev...eating patients with chronic pain." On April 21, alpharma announced that it withdrew its New Drug Applicatio...

Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions

...AID TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a leading global specialty pha...lerability and positive pharmacokinetic profile of alpharma Pharmaceuticals' FLECTOR(R) Patch (diclofenac epol... President, Clinical Research and Medical Affairs, alpharma Pharmaceuticals. "In addition to supporting the ef...

Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid

...h & Medical Affairs and Senior Vice President, alpharma Pharmaceuticals LLC. "We are committed to offering...="http://www.kadian.com/">www.KADIAN.com . About alpharma alpharma Inc. is a global specialty pharmaceutical company ...
Alpharma in Biological Technology

DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective

CUPERTINO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that the previously announced development and license agreement with Alpharma Ireland Limited, an affiliate of Alpharma Inc. (NYSE: ALO ), granting such party the exclusive worldwide right...

DURECT Corporation Announces Third Quarter 2008 Financial Results

... receipt of a $20 million upfront license fee from alpharma in the fourth quarter of 2008 and a review of proj...r us was the establishment of a collaboration with alpharma to develop and commercialize our ELADUR(TM) bupiva...ered into a development and license agreement with alpharma Ireland Ltd., an affiliate of Alpharma, Inc., gran...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ALNY ) alpharma INC. (NYSE: ALO ) ALTUS PHARMACEUTICALS INC. (NASDAQ: ALTU ) AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG ) ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP)...

Informed Medical Communications Appoints New Chief Financial Officer

...shares doubled and the company saw a dramatic improvement in cash flow. Prior to this, Marchio helped finance the domestic and international growth of alpharma from under $300MM in sales (1992) to approximately $1.3B (2005) while building treasury, tax, risk management and benefit finance systems as their Vic...

Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales

...o market, specifically with testing products and in the diabetes arena." Prior to joining Synvista, Mr. Tantillo was Director Strategic Marketing at alpharma Pharmaceuticals. From 2006 to 2007, he was U.S. Marketing Director at Mayne Pharma, which was acquired by Hospira. Prior to that, from 2004 to 2005 he...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...uticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI ...
Other Tags
(Date:4/18/2014)... The Gerontologist reports that among ... a decrease in anxiety about death and increases in ... lives. In particular, listening to gospel music is associated ... increase in sense of control. , These associations are ... individuals of both low- and high-socioeconomic status. , The ...
(Date:4/18/2014)... Medicine researchers have been awarded two-year grants for their ... this month. Of the 110 initial submissions to the ... Program, only four projects were funded, three of which ... Powell, M.D., Ph.D.; G. William Wong, Ph.D.; and Elias ... of oncology, will use his $500,000 proof of principle ...
(Date:4/18/2014)... 2014) Benaroya Research Institute at Virginia Mason (BRI) ... particular molecule in metastatic breast cancer reduces both the ... metastases. BRI scientists have found in models of the ... 60 - 80 percent and can keep the tumor ... million five-year grant comes from the National Cancer Institute ...
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2
(Date:4/17/2014)... engineer has developed a patented technique that improves ... The same technique could help police during drug ... Kay L. Theede chair in engineering and department ... research team have created a template-based system that ... The distance detection method called stand-off bomb ...
(Date:4/17/2014)... is available in German . ... the protection money demanded of him, he can expect his ... however, as fear of the consequences is enough to make ... parasitic birds, which lay their eggs in other birds, nests. ... brood parasites take their revenge by destroying the entire nest. ...
(Date:4/17/2014)... many serious conditions such as heart disease, epilepsy and ... therapies. Unfortunately, there is still much scientists do not ... and unexpected insight into the structure of sodium channels ... - which are responsible for ,fine-tuning, the activity of ... recent edition of the Journal of Biological Chemistry ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Structure of sodium channels different than previously believed 2
Other Contents